» Articles » PMID: 23053635

Structural Remodeling of Proteoglycans Upon Retinoic Acid-induced Differentiation of NCCIT Cells

Overview
Journal Glycoconj J
Publisher Springer
Date 2012 Oct 12
PMID 23053635
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Pluripotent and multipotent cells become increasingly lineage restricted through differentiation. Alterations to the cellular proteoglycan composition and structure should accompany these changes to influence cell proliferation, delineation of tissues and acquisition of cell migration capabilities. Retinoic acid plays an important role in pre-patterning of the early embryo. Retinoic acid can be used in vitro to induce differentiation, causing pluripotent and multipotent cells to become increasingly lineage restricted. We examined retinoic acid-induced changes in the cellular proteoglycan composition of the well-characterized teratocarcinoma line NCCIT. Our analysis revealed changes in the abundance of transcripts for genes encoding core proteins, enzymes that are responsible for early and late linkage region biosynthesis, as well as enzymes for GAG chain extension and modification. Transcript levels for genes encoding core proteins used as backbones for polysaccharide synthesis revealed highly significant increases in expression of lumican and decorin, 1,500-fold and 2,800-fold, respectively. Similarly, glypican 3, glypican 5, versican and glypican 6 showed increases between 5 and 70-fold. Significant decreases in biglycan, serglycin, glypican 4, aggrecan, neurocan, CD74 and glypican 1 were observed. Disaccharide analysis of the glycans in heparin/heparan sulfate and chondroitin/dermatan sulfate revealed retinoic acid-induced changes restricted to chondroitin/dermatan sulfate glycans. Our study provides the first detailed analysis of changes in the glycosaminoglycan profile of human pluripotent cells upon treatment with the retinoic acid morphogen.

Citing Articles

LncRNA PNKY Is Upregulated in Breast Cancer and Promotes Cell Proliferation and EMT in Breast Cancer Cells.

Hakiminia F, Jannat Alipoor F, Keshavarz M, Asadi M Noncoding RNA. 2023; 9(2).

PMID: 37104007 PMC: 10143469. DOI: 10.3390/ncrna9020025.


Differential Expression Profile of ZFX Variants Discriminates Breast Cancer Subtypes.

Pourkeramati F, Asadi M, Shakeri S, Farsinejad A Iran Biomed J. 2018; 23(1):47-56.

PMID: 29753316 PMC: 6305825.


Decorin in Human Colon Cancer: Localization In Vivo and Effect on Cancer Cell Behavior In Vitro.

Nyman M, Sainio A, Pennanen M, Lund R, Vuorikoski S, Sundstrom J J Histochem Cytochem. 2015; 63(9):710-20.

PMID: 26001829 PMC: 4804730. DOI: 10.1369/0022155415590830.


Profiling of Proteins Regulated by Venlafaxine during Neural Differentiation of Human Cells.

Doh M, Han D, Oh D, Kim S, Choi M, Chai Y Psychiatry Investig. 2015; 12(1):81-91.

PMID: 25670950 PMC: 4310925. DOI: 10.4306/pi.2015.12.1.81.


Chondroitin sulfate proteoglycans: structure-function relationship with implication in neural development and brain disorders.

Avram S, Shaposhnikov S, Buiu C, Mernea M Biomed Res Int. 2014; 2014:642798.

PMID: 24955366 PMC: 4052930. DOI: 10.1155/2014/642798.


References
1.
Grobe K, Ledin J, Ringvall M, Holmborn K, Forsberg E, Esko J . Heparan sulfate and development: differential roles of the N-acetylglucosamine N-deacetylase/N-sulfotransferase isozymes. Biochim Biophys Acta. 2002; 1573(3):209-15. DOI: 10.1016/s0304-4165(02)00386-0. View

2.
Aikawa J, Esko J . Molecular cloning and expression of a third member of the heparan sulfate/heparin GlcNAc N-deacetylase/ N-sulfotransferase family. J Biol Chem. 1999; 274(5):2690-5. DOI: 10.1074/jbc.274.5.2690. View

3.
Funderburgh J, Caterson B, Conrad G . Keratan sulfate proteoglycan during embryonic development of the chicken cornea. Dev Biol. 1986; 116(2):267-77. DOI: 10.1016/0012-1606(86)90130-2. View

4.
Lanctot P, Gage F, Varki A . The glycans of stem cells. Curr Opin Chem Biol. 2007; 11(4):373-80. PMC: 2697851. DOI: 10.1016/j.cbpa.2007.05.032. View

5.
Troup S, Njue C, Kliewer E, Parisien M, Roskelley C, Chakravarti S . Reduced expression of the small leucine-rich proteoglycans, lumican, and decorin is associated with poor outcome in node-negative invasive breast cancer. Clin Cancer Res. 2003; 9(1):207-14. View